Goldman Urology has announced the adoption of 'UROSTONE', an extracorporeal shock wave lithotripter integrated with the latest artificial intelligence (AI) technology, as of November 4th. The device is equipped with an AI Breath-Trigger System and AI Auto-Focusing capability—both registered as domestic patents—significantly enhancing the precision and efficiency of kidney stone treatments.
Conventional lithotripters faced a key limitation: when a patient's breathing caused slight shifts in the stone's position, the shock wave would miss its target, reducing efficacy. UROSTONE overcomes this by using AI to analyze the patient's breathing patterns in real time and track even minute stone movements, automatically re-adjusting the shock wave trajectory. This ensures the shock wave consistently targets the center of the stone, dramatically improving fragmentation efficiency and reducing procedure time.
Additionally, the device features Korea's only AI image recognition-based auto-focusing capability. This technology independently analyzes and adjusts the focal point on the stone's location, maximizing procedural accuracy without manual intervention from the physician.
A Goldman Urology representative stated, "Since AI simultaneously detects the patient's breathing and the stone's movement and automatically adjusts the optimal shock wave, more precise and safer stone fragmentation is possible. We expect high patient satisfaction as procedure time is reduced and the burden of pain and repeat treatments decreases."